查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678546

避孕藥具和設備市場規模、佔有率、趨勢分析報告：產品、地區、細分市場預測，2025-2030 年

Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計 2024 年全球避孕藥和避孕設備的市場規模將達到 311.8 億美元，2025 年至 2030 年的複合年成長率為 6.0%。

有幾個因素推動了避孕藥市場的成長。主要促進因素包括提高生殖健康意識和教育、對計劃生育方法的需求不斷成長、改善衛生基礎設施和獲取途徑、以及改變消費者對更有效和更方便的避孕選擇的偏好。這些因素導致全球對更廣泛的避孕選擇的需求，包括口服避孕藥和長效可逆避孕藥（LARC），如子宮內避孕器（IUD）和植入。

此外，對於青少年懷孕的健康問題、對現代避孕方法的認知不斷提高以及對口服避孕藥作為預防意外懷孕的主要手段的偏好日益增加，預計將在預測期內推動市場成長。此外，不斷增加的產品創新、政府措施以及對婦女賦權和權利的關注也促進了該市場的成長。例如，2023年7月，純孕激素口服避孕藥Opil獲得FDA核准用於非合併使用。

在預計預測期內，旨在減少意外懷孕和相關醫療費用的計劃的實施以及用戶意識的提高將推動該行業的發展。根據聯合國人口基金會（UNFPA）的《2022年世界人口狀況報告》，全球每年約有1.21億人懷孕，其中近一半是意外懷孕。

此外，開發中國家的政府正在採取措施提高人們的避孕意識並增加人們獲得避孕的機會。例如，2023年10月，印度卡納塔克邦衛生署在國家計劃生育計劃下推出了兩種新的女性避孕方法。政府營運的健康中心將提供皮下植入和注射劑，透過延長兩次生育之間的時間來促進生殖健康和性健康。這些避孕方法可望推動新興市場的避孕，並有助於市場發展。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 避孕藥與避孕設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰
    • 市場機會分析
  • 避孕藥具與避孕設備市場分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章 避孕藥具和設備市場：按產品分類的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年產品市場佔有率分析
  • 細分儀表板
  • 2018 年至 2030 年避孕藥具及避孕設備市場（依產品分類）
    • 避孕藥
    • 避孕裝置

第 5 章 避孕藥具和設備市場：按地區分類的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2024 年和 2030 年避孕藥具和避孕設備各地區市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭格局

  • 主要市場參與企業的最新趨勢/策略措施及影響分析
  • 公司分類
  • 企業市場分析
  • 戰略地圖
  • 公司簡介
    • AbbVie Inc.
    • Afaxys, Inc.
    • Agile Therapeutics
    • Bayer AG
    • China Resources（Holdings）Co., Ltd.
    • Church & Dwight Co., Inc.
    • Cupid Limited
    • Helm AG
    • Johnson & Johnson Services, Inc.
    • Organon Group
    • Pfizer Inc.
    • Veru, Inc.
    • Viatris Inc.
Product Code: 978-1-68038-032-3

Market Size & Trends:

The global contraceptive drugs and devices market size was estimated at USD 31.18 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. Several factors are contributing to the growth of the contraceptive market. Increasing awareness and education about reproductive health, a rising demand for family planning methods, improved healthcare infrastructure and access, and a shift in consumer preferences toward more effective and convenient contraceptive options are all key drivers. These factors have led to a global demand for a wide range of contraceptive choices, including oral contraceptives and long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants.

Furthermore, health concerns related to teenage pregnancies, increased awareness of modern contraception methods, and a growing preference for oral contraceptives as the primary means of preventing unplanned pregnancies are anticipated to drive market growth during the forecast period. In addition, advancements in product innovation, government initiatives, and a focus on women's empowerment and rights have contributed to this market growth. For instance, in July 2023, Opill, a progestin-only oral contraceptive pill, got approval by the FDA for nonprescription use.

Implementing programs aimed at reducing unwanted pregnancies and related healthcare costs, along with increasing awareness among users, is expected to drive growth in the industry during the forecast period. According to the 2022 State of World Population Report by the United Nations Population Fund (UNFPA), approximately 121 million pregnancies occur worldwide each year, with nearly half of them being unintended.

Moreover, governments in developing countries are undertaking steps to increase awareness and access to contraceptives. For instance, in October 2023, the Karnataka Health Department in India launched two new contraceptive methods for women under the National Family Planning Programme. The sub-dermal implant and subcutaneous injection were made available at government-run health centers to promote reproductive and sexual health by extending the interval between two births. Such methods are expected to promote the use of contraception in developing countries and contribute to the market's growth.

Global Contraceptive Drugs And Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product, and region.

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectable
  • Contraceptive Devices
    • Condoms
    • Male Condoms
    • Female Condoms
    • Subdermal Implants
    • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
    • Vaginal Ring
    • Diaphragm
  • Regional Outlook (Revenue, USD Billion, 2018-2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Secondary Sources
    • 1.4.2. List of Primary Sources
    • 1.4.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamic
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing awareness and education on reproductive health
      • 3.2.1.2. Rising demand for family planning methods
      • 3.2.1.3. Growing healthcare infrastructure and access
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects and health concerns
    • 3.2.3. Industry Challenges
    • 3.2.4. Market Opportunity Analysis
  • 3.3. Contraceptive Drugs and Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Contraceptive Drugs and Devices Market: By Product, 2018 to 2030
    • 4.4.1. Contraceptive Drugs
      • 4.4.1.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.2. Contraceptive Pills
        • 4.4.1.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.3. Patch
        • 4.4.1.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.4. Injectable
        • 4.4.1.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Contraceptive Devices
      • 4.4.2.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.2. Condoms
        • 4.4.2.2.1. Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.2.2. Male Condoms
          • 4.4.2.2.2.1. Male Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.2.3. Female Condoms
          • 4.4.2.2.3.1. Female Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.3. Subdermal Implants
        • 4.4.2.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.4. Intrauterine Devices (IUDs)
        • 4.4.2.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.4.2. Copper IUDs
          • 4.4.2.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.4.3. Hormonal IUDs
          • 4.4.2.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.5. Vaginal Ring
        • 4.4.2.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.6. Diaphragm
        • 4.4.2.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis by Region, Product

  • 5.1. Definition and Scope
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Regional Market Dashboard
  • 5.4. Contraceptive Drugs and Devices Market Share, By Region, 2024 & 2030, (USD Billion)
  • 5.5. North America
    • 5.5.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.2. U.S.
      • 5.5.2.1. U.S. Key Country Dynamics
      • 5.5.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Canada
      • 5.5.3.1. Canada Key Country Dynamics
      • 5.5.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. Mexico
      • 5.5.4.1. Mexico Key Country Dynamics
      • 5.5.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Europe
    • 5.6.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. UK
      • 5.6.2.1. UK Key Country Dynamics
      • 5.6.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. U.K. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. Germany
      • 5.6.3.1. Germany Key Country Dynamics
      • 5.6.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. France
      • 5.6.4.1. France Key Country Dynamics
      • 5.6.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. Italy
      • 5.6.5.1. Italy Key Country Dynamics
      • 5.6.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. Spain
      • 5.6.6.1. Spain Key Country Dynamics
      • 5.6.6.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Denmark
      • 5.6.7.1. Denmark Spain Key Country Dynamics
      • 5.6.7.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.8. Sweden
      • 5.6.8.1. Sweden Key Country Dynamics
      • 5.6.8.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.8.3. Competitive Insights
      • 5.6.8.4. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.9. Norway
      • 5.6.9.1. Norway Key Country Dynamics
      • 5.6.9.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.9.3. Competitive Insights
      • 5.6.9.4. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.2. China
      • 5.7.2.1. China Key Country Dynamics
      • 5.7.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.3. Japan
      • 5.7.3.1. Japan Key Country Dynamics
      • 5.7.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.4. India
      • 5.7.4.1. India Key Country Dynamics
      • 5.7.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.4.3. Competitive Insights
      • 5.7.4.4. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.5. South Korea
      • 5.7.5.1. South Korea Key Country Dynamics
      • 5.7.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.5.3. Competitive Insights
      • 5.7.5.4. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.6. Australia
      • 5.7.6.1. Australia Key Country Dynamics
      • 5.7.6.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.6.3. Competitive Insights
      • 5.7.6.4. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.7. Thailand
      • 5.7.7.1. Thailand Key Country Dynamics
      • 5.7.7.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.7.3. Competitive Insights
      • 5.7.7.4. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Latin America
    • 5.8.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.2. Brazil
      • 5.8.2.1. Brazil Key Country Dynamics
      • 5.8.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.3. Argentina
      • 5.8.3.1. Argentina Key Country Dynamics
      • 5.8.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Middle East and Africa (MEA)
    • 5.9.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.2. South Africa
      • 5.9.2.1. South Africa Key Country Dynamics
      • 5.9.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.2.3. Competitive Insights
      • 5.9.2.4. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Saudi Arabia Key Country Dynamics
      • 5.9.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.3.3. Competitive Insights
      • 5.9.3.4. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.4. UAE
      • 5.9.4.1. UAE Key Country Dynamics
      • 5.9.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.4.3. Competitive Insights
      • 5.9.4.4. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.5. Kuwait
      • 5.9.5.1. Kuwait Key Country Dynamics
      • 5.9.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.5.3. Competitive Insights
      • 5.9.5.4. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments/ Strategic Initiatives & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Position Analysis
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles
    • 6.5.1. AbbVie Inc.
      • 6.5.1.1. Participant's Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Recent Developments/ Strategic Initiatives
    • 6.5.2. Afaxys, Inc.
      • 6.5.2.1. Participant's Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Recent Developments/ Strategic Initiatives
    • 6.5.3. Agile Therapeutics
      • 6.5.3.1. Participant's Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Recent Developments/ Strategic Initiatives
    • 6.5.4. Bayer AG
      • 6.5.4.1. Participant's Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Recent Developments/ Strategic Initiatives
    • 6.5.5. China Resources (Holdings) Co., Ltd.
      • 6.5.5.1. Participant's Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Recent Developments/ Strategic Initiatives
    • 6.5.6. Church & Dwight Co., Inc.
      • 6.5.6.1. Participant's Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Recent Developments/ Strategic Initiatives
    • 6.5.7. Cupid Limited
      • 6.5.7.1. Participant's Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Recent Developments/ Strategic Initiatives
    • 6.5.8. Helm AG
      • 6.5.8.1. Participant's Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Recent Developments/ Strategic Initiatives
    • 6.5.9. Johnson & Johnson Services, Inc.
      • 6.5.9.1. Participant's Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Recent Developments/ Strategic Initiatives
    • 6.5.10. Organon Group
      • 6.5.10.1. Participant's Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Recent Developments/ Strategic Initiatives
    • 6.5.11. Pfizer Inc.
      • 6.5.11.1. Participant's Overview
      • 6.5.11.2. Financial Performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Recent Developments/ Strategic Initiatives
    • 6.5.12. Veru, Inc.
      • 6.5.12.1. Participant's Overview
      • 6.5.12.2. Financial Performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Recent Developments/ Strategic Initiatives
    • 6.5.13. Viatris Inc.
      • 6.5.13.1. Participant's Overview
      • 6.5.13.2. Financial Performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 4 U.S. contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 5 Canada contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 6 Mexico contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 7 Europe contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 8 UK contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 9 Germany contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 10 France contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 11 Italy contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 12 Spain contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 13 Denmark contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 14 Sweden contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 15 Norway contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 17 Japan contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 18 China contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 19 India contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 20 Australia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 21 South Korea contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 22 Thailand contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 23 Latin America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 24 Brazil contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 25 Argentina contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 26 MEA contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 27 South Africa contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 28 Saudi Arabia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 29 UAE contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 30 Kuwait contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Contraceptive Drugs and Devices Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 Contraceptive Drugs and Devices- Market Size and Growth Prospects (USD Billion)
  • Fig. 11 Contraceptive Drugs and Devices Market: Market Dynamics
  • Fig. 12 Contraceptive Drugs and Devices Market: PORTER's Analysis
  • Fig. 13 Contraceptive Drugs and Devices Market: PESTEL Analysis
  • Fig. 14 Contraceptive Drugs and Devices Market Share by Product 2024 & 2030 (USD Billion)
  • Fig. 15 Contraceptive Drugs and Devices Market, by Product: Key Takeaways
  • Fig. 16 Contraceptive Drugs and Devices Market, by Product: Market Share, 2024 & 2030
  • Fig. 17 Contraceptive Drugs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 18 Contraceptive Pills Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 19 Patch Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 20 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 21 Contraceptive Devices Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 22 Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 23 Male Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 24 Female Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 25 Subdermal Implants Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 26 Intrauterine Devices (IUDs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 27 Copper IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 28 Hormonal IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 29 Vaginal Ring Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 30 Diaphragm Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 31 Contraceptive Drugs and Devices Market Revenue, by Region, 2024 & 2030 (USD Billion)
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030) (USD Billion)
  • Fig. 40 Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 MEA Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Key Company Categorization
  • Fig. 63 Company Market Positioning
  • Fig. 64 Key Company Market Share Analysis, 2024
  • Fig. 65 Strategic Framework